Artal Group S.A. Amarin Corp Plcuk Transaction History
Artal Group S.A.
- $129 Million
- Q2 2025
A detailed history of Artal Group S.A. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Artal Group S.A. holds 500,000 shares of AMRN stock, worth $8.37 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
500,000Holding current value
$8.37 Million% of portfolio
0.42%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding AMRN
# of Institutions
28Shares Held
3.61MCall Options Held
0Put Options Held
0-
Longitude (Cayman) Ltd. Grand Cayman, E91.62MShares$27.1 Million1.11% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL683KShares$11.4 Million0.0% of portfolio
-
Sawtooth Solutions, LLC469KShares$7.85 Million0.01% of portfolio
-
Regis Management CO LLC350KShares$5.86 Million0.07% of portfolio
-
Black Rock Inc. New York, NY270KShares$4.52 Million0.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $6.75B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...